PHX

0.00%

4.7¢ pharmx technologies limited

Ann: Half Yearly Report and Accounts, page-3

First 3 Last

Share
Profile

Follow
spider_webb

90 Posts.

1

28/02/18

17:43

Post #: 31424917
Share

Originally posted by roboshan ↑

As foreshadowed the revenue decline continues but there is a small increase in profit. This represents part of the strategy to "adapt the organisation to its revenue base." I believe the customer base has now stabilised at just over a 20% market share following the loss of some pharmacy groups including Chemist Warehouse who have developed and progressively rolled out their own dispensary software platform. Corum's cash bucket has only decreased slightly following the recent R&D tax benefits so not a bad position considering a $2m spend on R&D/Product Development. So Corum is essentially funding new product development out of current revenues. The large proportional spend on R&D should decrease in FY19 and along with other cost reductions provide improved profitability expected.

The roll out of new products seems a bit behind schedule but it is important to perfect these before general release. So we have to wait a little longer to see any increase revenue and satisfactory return on investment from them. The position is that investors now want to see a turn around and will not tolerate any further revenue decline taking particular note of the statement;

"Corum is working on specific opportunities for future growth and will advise the market further at the appropriate time."

Expand

The business still doesn't look healthy to me, looking at the negative operational cash flows makes me queasy... are we investing in a story or results?

COO Price at posting: 3.8¢ Sentiment: Hold Disclosure: Held
2 Upvote

1 Great analysis

Reply

Top Stories

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

There are more pages in this discussion • 4 more messages in this thread...

First 3 Last

Add PHX (ASX) to my watchlist

(20min delay)
Last 4.7¢		Change 0.000(0.00%)		Mkt cap ! $28.12M

Open	High	Low	Value	Volume
4.7¢	4.7¢	4.7¢	$940	20K

Buyers (Bids)

No.	Vol.	Price($)
1	83300	4.4¢

Sellers (Offers)

Price($)	Vol.	No.
4.7¢	174999	3

View Market Depth

No.	Vol.	Price($)
1	83300	0.044
1	78187	0.043
1	13940	0.042
1	137600	0.041
1	165000	0.040

Price($)	Vol.	No.
0.047	174999	3
0.050	324438	3
0.055	555000	3
0.057	500000	1
0.080	50000	1

Last trade - 10.06am 04/10/2024 (20 minute delay)

PHX (ASX) Chart

Ann: Half Yearly Report and Accounts, page-3

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Half Yearly Report and Accounts, page-3

Top Stories

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News